MEIP
MEI Pharma Inc
Halal Rating :
Last Price
$2.80
Last updated:
Market Cap
-
7D Change
2.94%
1 Year Change
-39.13%
Company Overview
Industries
Exchange
Next Earnings Date
MEI Pharma, Inc. is a clinical-stage pharmaceutical company focused on developing novel cancer therapies. The company has been primarily involved in research and development of drug candidates for the treatment of various types of cancer. Their development pipeline has included drug candidates targeting both hematologic (blood) cancers and solid tumors.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate MEI Pharma Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.